Print

ThromboGenics Ltd. (THR.BR) to Absorb Subsidiary Thromb-X, NV  
5/23/2007 11:08:08 AM

BRUSSELS (Thomson Financial) - Belgian biotechnology company ThromboGenics NV said it plans to absorb its subsidiary Thromb-X. The company said the transaction will issue no new shares or cash payment.
//-->